← Eichor
Study identifier: NCT05892042 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

Condition: ST-segment Elevation Myocardial Infarction (STEMI) · Left Ventricular Thrombus  ·  Sponsor: Jilin University

PhaseNA
Planned participants320
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction

This description comes directly from the study's public registry record.

Talk to the study team

Mingyou Zhang  ·  86-431-88782342  ·  zmy@jlu.edu.cn

Zhaoxi Liu  ·  86-431-88782342

Always discuss trial participation with your own doctor first.

Locations (1)

Jilin universityChangchun, Jilin, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05892042